Oncology Essentials

Individualizing Care for Women With Early-Stage Breast Cancer: The Role of Molecular Assays

Georgia Litsas

molecular testing, breast cancer, genetics, personalized medicine
CJON 2013, 17(3), 332-334. DOI: 10.1188/13.CJON.332-334

Traditionally, a variety of factors were used to make adjuvant treatment decisions in breast cancer, but none of those factors, except grade, has a consistent association with sensitivity to chemotherapy or endocrine therapy. However, oncologists now are able to use molecular assays as a component of decision making for adjuvant therapy. This article focuses on the use of two of those molecular assays and their implications for nurses.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.